Bolt Biotherapeutics, Inc.
BOLT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $10,211 | $11,065 | $306,718 | $409,655 |
| - Cash | $17,753 | $9,601 | $8,391 | $7,205 |
| + Debt | $23,589 | $24,183 | $24,709 | $25,209 |
| Enterprise Value | $16,047 | $25,647 | $323,036 | $427,659 |
| Revenue | $2,169 | $1,804 | $1,222 | $0 |
| % Growth | 20.2% | 47.6% | – | – |
| Gross Profit | $1,879 | $1,804 | $1,222 | -$426 |
| % Margin | 86.6% | 100% | 100% | – |
| EBITDA | -$6,854 | -$8,863 | -$11,716 | -$15,510 |
| % Margin | -316% | -491.3% | -958.8% | – |
| Net Income | -$7,144 | -$8,561 | -$11,040 | -$15,936 |
| % Margin | -329.4% | -474.6% | -903.4% | – |
| EPS Diluted | -3.722 | -4.46 | -0.29 | -0.42 |
| % Growth | 16.5% | -1,437.9% | 31% | – |
| Operating Cash Flow | -$9,732 | -$9,597 | -$13,365 | -$14,430 |
| Capital Expenditures | -$72 | $0 | $0 | $0 |
| Free Cash Flow | -$9,804 | -$9,597 | -$13,365 | -$14,430 |